Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haleigh Mistry

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of the Advanced Practitioner in Oncology|June 6, 2022
Biomarker JeopardySandra E Kurtin, Alyssa Henglefelt, Haleigh Mistry
Clinical Journal of Oncology Nursing|March 19, 2017
Toxicity Management: Development of a Novel and Immune-Mediated Adverse Events Algorithm
Haleigh Mistry, Sheryl G Forbes, Nathan Fowler
Leukemia & Lymphoma|October 11, 2018
Response to pembrolizumab and lenalidomide in advanced refractory mycosis fungoidesEric Fountain, Haleigh Mistry, Preetesh Jain, et al.
Journal of the Advanced Practitioner in Oncology|August 7, 2025
Supporting Administrative Time for Advanced Practitioners: A Comprehensive ApproachMerdith Beaton, Andrea Edwards, Wendy Vogel, et al.
JCO Oncology Practice|January 30, 2026
Development of a Multidisciplinary Adolescent and Young Adult Program at a Large Academic Cancer CenterMichael E Roth, Wendy Griffith, Eunju Choi, et al.
Blood Advances|January 11, 2022
Day 30 SUVmax predicts progression in patients with lymphoma achieving PR/SD after CAR T-cell therapyAjlan Al Zaki, Lei Feng, Grace Watson, et al.
Haematologica|November 17, 2022
Axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma patients in complete metabolic responseAndrew P Jallouk, Sushanth Gouni, Jason Westin, et al.
Leukemia|September 20, 2022
Impact of conditioning chemotherapy on lymphocyte kinetics and outcomes in LBCL patients treated with CAR T-cell therapyPaolo Strati, Andrew P Jallouk, Ryan Sun, et al.
Blood|February 3, 2021
Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphomaPaolo Strati, Sairah Ahmed, Fateeha Furqan, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of the Advanced Practitioner in Oncology|June 6, 2022
Biomarker JeopardySandra E Kurtin, Alyssa Henglefelt, Haleigh Mistry
Clinical Journal of Oncology Nursing|March 19, 2017
Toxicity Management: Development of a Novel and Immune-Mediated Adverse Events Algorithm
Haleigh Mistry, Sheryl G Forbes, Nathan Fowler
Leukemia & Lymphoma|October 11, 2018
Response to pembrolizumab and lenalidomide in advanced refractory mycosis fungoidesEric Fountain, Haleigh Mistry, Preetesh Jain, et al.
Journal of the Advanced Practitioner in Oncology|August 7, 2025
Supporting Administrative Time for Advanced Practitioners: A Comprehensive ApproachMerdith Beaton, Andrea Edwards, Wendy Vogel, et al.
JCO Oncology Practice|January 30, 2026
Development of a Multidisciplinary Adolescent and Young Adult Program at a Large Academic Cancer CenterMichael E Roth, Wendy Griffith, Eunju Choi, et al.
Blood Advances|January 11, 2022
Day 30 SUVmax predicts progression in patients with lymphoma achieving PR/SD after CAR T-cell therapyAjlan Al Zaki, Lei Feng, Grace Watson, et al.
Haematologica|November 17, 2022
Axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma patients in complete metabolic responseAndrew P Jallouk, Sushanth Gouni, Jason Westin, et al.
Leukemia|September 20, 2022
Impact of conditioning chemotherapy on lymphocyte kinetics and outcomes in LBCL patients treated with CAR T-cell therapyPaolo Strati, Andrew P Jallouk, Ryan Sun, et al.
Blood|February 3, 2021
Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphomaPaolo Strati, Sairah Ahmed, Fateeha Furqan, et al.
Pageof 1